Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Anuh Pharma Limited (NSE: ANUHPHR), ISIN INE489G01022 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ANUHPHR last traded at ₹83.45 (+2.33%), with a 52-week range of ₹66.72 to ₹99.50 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 71.80%, FIIs 0.11%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 53/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.